ventilator associated pneumonia: microbiology and identification of antimicrobial resistance pattern by disk diffusion and e.test methods

Authors

mahshid talebi taher rasoul-e-akram hospital, iran university of medical science, tehran, ir iran; rasoul-e-akram hospital, iran university of medical science, tehran, ir iran

seyed ali javad mousavi rasoul-e-akram hospital, iran university of medical science, tehran, ir iran

habib malek pour rasoul-e-akram hospital, iran university of medical science, tehran, ir iran

abstract

background ventilator- associated pneumonia (vap) continues to complicate the course of 8-28 % patients receiving mechanical ventilation. the mortality rate for vap is high, ranges from 24-50% and can reach 76% in some specific settings or when lung infection is caused by high risk pathogens. the etiologic agents widely differ according to the population of patients in an intensive care unit, duration of hospital stay, and prior antimicrobial therapy. because appropriate antimicrobial treatment of patients with vap significantly improves outcome, more rapid identification of infected patients and selection of antimicrobial agents represent important clinical goals. our goal was determination of the vap incidence, identification of common pathogenic causes and determination of antimicrobial resistance pattern by disk-diffusion and e.test methods. materials and methods in an observational study we evaluated the microbiology and antimicrobial resistance pattern of vap in medical intensive care units (icus) of 2 teaching hospitals from january 2005 to january 2006. diagnostic criteria for vap were the radiographic appearance of a new or progressive and persistent pulmonary infiltrate in conjunction with at least 2 of the following criteria: purulent respiratory secretions, temperature > 38.5 °c or < 35°c, leukocyte count >10,000 mm3 or < 1,500/mm3. mini–bal was planned for all of suspicious cases. for each causative pathogen, antibiotic susceptibility was determined by disk-diffusion and e.test methods. results among 114 patients under mechanical ventilation, 6 patients (5.3%) had a vap episode, 3 patients in each hospital. in vap patients the mean days of hospitalization were 26.3 days (± 20.92) and icu stay were 22.8 days (± 21.53). there was a significant statistical correlation between use of h2 blockers and vap (p< 0.05). pseudomonas aeruginosa and klebsiella pneumonia were isolated by mini-bal (>104cfu/ml) in 6 patients (each pathogen in 3 cases). antimicrobial susceptibility pattern were determined by disk-diffusion and e.test methods and all of pathogens except one (pseudomonas aeruginosa) were resistant to ceftriaxone and ceftazidime. conclusion this study showed the increasing incidence of resistance to third and fourth generations of cephalosporins among gram negative bacilli that has occurred in parallel with increasing use of these drugs in our icus. more judiciouse use of antibiotics will be necessary to limit this trend.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Ventilator Associated Pneumonia by Acinetobacter baumannii And antimicrobial susceptibility pattern

Background: Ventilator Associated Pneumonia (VAP) is one of the serious complications of ventilator support occurring in ICUs. The aim of this study was to determine the susceptibility pattern of Acinetobacter baumannii (A. baumannii) isolated from patients with VAP by two methods: disk diffusion and E. test. Methods: This descriptive-cross sectional study was conducted in the four ICUs of Ras...

full text

Detection Of Methicillin Resistance In Staphylococcus Aureus By Disk Diffusion And PCR Methods

  Background and Objective: Methicillin resistance in Staphylococcus aureus is an increasingly important clinical problem. A chromosomal gene, mecA, mediates resistance to penicillinase-resistant penicillins such as methicillin and oxacillin in Staphylococcus aureus. We evaluated the validity of disk diffusion test by using oxacillin, methicillin an...

full text

The microbiology of ventilator-associated pneumonia.

Ventilator-associated pneumonia (VAP) is a common complication of ventilatory support for patients with acute respiratory failure and is associated with increased morbidity, mortality, and costs. Awareness of the microbiology of VAP is essential for selecting optimal antibiotic therapy and improving these outcomes. The specific microbial causes of VAP are many and varied. Most cases of VAP are ...

full text

Ventilator associated pneumonia: bacterial isolates and its antibiotic resistance pattern

Keywords: Amp C ß lactamase Extended spectrum ß lactamase Metallobetalactamase Multidrug resistant organisms Ventilator associated pneumonia. Aims: Ventilator Associated Pneumonia (VAP) is the most frequent intensive care unit (ICU) acquired infection. Due to the increasing incidence of multidrug resistant organisms (MDR) in the ICU, early and correct diagnosis of VAP is an urgent challenge for...

full text

Antimicrobial treatment of ventilator-associated pneumonia.

Ventilator-associated pneumonia is a common complication of ventilatory support for patients with acute respiratory failure and is associated with increased morbidity, mortality, and costs. Optimal antimicrobial therapy is an essential part of successful management of ventilator-associated pneumonia. Numerous safe and effective antimicrobial drugs are available, and their efficacy can be optimi...

full text

Microbiological Pattern of Ventilator Associated Pneumonia.

BACKGROUND Ventilator associated pneumonia (VAP) is an important and common complication of mechanically ventilated patients. It is the leading cause of morbidity and mortality in Intensive Care Units (ICU) worldwide. The aim of study was to determine the pattern of bacteria involved in VAP in intensive care unit of Jinnah hospital Lahore. METHODS It was descriptive case series study, conduct...

full text

My Resources

Save resource for easier access later


Journal title:
archives of clinical infectious diseases

جلد ۳، شماره ۱، صفحات ۱۳-۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023